Cargando…
Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis
INTRODUCTION: Immune checkpoint inhibitors are used in the treatment of various cancers and have been extensively researched with regard to inflammatory and autoimmune diseases. However, this revolutionary therapeutic strategy often provokes critical auto-inflammatory adverse events, such as inflamm...
Autores principales: | Brom, Victoria C., Strauss, Andreas C., Sieberath, Alexander, Salber, Jochen, Burger, Christof, Wirtz, Dieter C., Schildberg, Frank A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931766/ https://www.ncbi.nlm.nih.gov/pubmed/36817431 http://dx.doi.org/10.3389/fimmu.2023.988365 |
Ejemplares similares
-
The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies
por: Brom, Victoria C., et al.
Publicado: (2022) -
Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System
por: Guder, Christian, et al.
Publicado: (2020) -
The Role of PD-1 in Acute and Chronic Infection
por: Jubel, Jil M., et al.
Publicado: (2020) -
sCD28, sCD80, sCTLA-4, and sBTLA Are Promising Markers in Diagnostic and Therapeutic Approaches for Aseptic Loosening and Periprosthetic Joint Infection
por: Jubel, Jil M., et al.
Publicado: (2021) -
Immunomodulatory potential of mesenchymal stromal cell-derived extracellular vesicles in chondrocyte inflammation
por: Ossendorff, Robert, et al.
Publicado: (2023)